Suppression of TLR4-MyD88 signaling pathway attenuated chronic mechanical pain in a rat model of endometriosis.
Suppression of TLR4-MyD88 signaling pathway attenuated chronic mechanical pain in a rat model of endometriosis.
复制标题
抑制 TLR4-MyD88 信号通路可减轻子宫内膜异位症大鼠模型的慢性机械性疼痛
DOI:
10.1186/s12974-020-02066-y
复制
发表时间:
2021-03-05
影响因子:
9.3
通讯作者:
Ma C
中科院分区:
文献类型:
--
作者:
Su W;Cui H;Wu D;Yu J;Ma L;Zhang X;Huang Y;Ma C
BackgroundAs a classic innate immunity pathway, Toll-like receptor 4 (TLR4) signaling has been intensively investigated for its function of pathogen recognition. The receptor is located not only on immune cells but also on sensory neurons and spinal glia. Recent studies revealed the involvement of neuronal TLR4 in different types of pain. However, the specific role of TLR4 signaling in the pain symptom of endometriosis (EM) remains obscure.MethodsThe rat endometriosis model was established by transplanting uterine horn tissue into gastrocnemius. Western blotting and/or immunofluorescent staining were applied to detect high mobility group box 1 (HMGB1), TLR4, myeloid differentiation factor-88 adaptor protein (MyD88), and nuclear factor kappa-B-p65 (NF-κB-p65) expression, as well as the activation of astrocyte and microglia. The antagonist of TLR4 (LPS-RS-Ultra, LRU) and MyD88 homodimerization inhibitory peptide (MIP) were intrathecally administrated to assess the behavioral effects of blocking TLR4 signaling on endometriosis-related pain.ResultsMechanical hyperalgesia was observed at the graft site, while HMGB1 was upregulated in the implanted uterine tissue, dorsal root ganglion (DRG), and spinal dorsal horn (SDH). Compared with sham group, upregulated TLR4, MyD88, and phosphorylated NF-κB-p65 were detected in the DRG and SDH in EM rats. The activation of astrocytes and microglia in the SDH was also confirmed in EM rats. Intrathecal application of LRU and MIP alleviated mechanical pain on the graft site of EM rats, with decreased phosphorylation of NF-κB-p65 in the DRG and reduced activation of glia in the SDH.ConclusionsHMGB1-TLR4-MyD88 signaling pathway in the DRG and SDH may involve in endometriosis-related hyperpathia. Blockade of TLR4 and MyD88 might serve as a potential treatment for pain in endometriosis.
登录
查看更多内容
DOI:
10.1016/j.bbi.2014.06.199
发表时间:
2014-11
期刊:
Brain, behavior, and immunity
影响因子:
--
作者:
Allette YM;Due MR;Wilson SM;Feldman P;Ripsch MS;Khanna R;White FA
通讯作者:
White FA
影响因子:
8.8
作者:
Das N;Dewan V;Grace PM;Gunn RJ;Tamura R;Tzarum N;Watkins LR;Wilson IA;Yin H
通讯作者:
Yin H
影响因子:
4
作者:
Bestall SM;Hulse RP;Blackley Z;Swift M;Ved N;Paton K;Beazley-Long N;Bates DO;Donaldson LF
通讯作者:
Donaldson LF
影响因子:
2.7
作者:
Flyckt, Rebecca;Kim, Suejin;Falcone, Tommaso
通讯作者:
Falcone, Tommaso
影响因子:
3
作者:
Mazur, Curt;Fitzsimmons, Bethany;Wancewicz, Ed
通讯作者:
Wancewicz, Ed